StockWatch
·

GREENPLY INDUSTRIES LTD. Q2 FY27 Results

GREENPLYQ2 FY27 Results
Filing
Result:Steady· Market: Crashed#Margin expansion#Base effect#Broad based

Outlook: Cautiously Optimistic · Guidance: Cut

MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue799.6910.3%16.1%
Total Income803.1710.5%16.4%
Expenditure739.9510.2%11.9%
PBT63.2214.6%116.6%
Net Profit42.7313.6%167.3%
OPM11.16%0.36pp2.92pp
NPM5.32%0.14pp3.00pp
EPS3.4213.6%167.2%
View full financials

Manufacturing/consumer lens: revenue +16.1% YoY with OPM expanding 292bps and PAT at a 6-quarter high, but a large chunk of the PAT surge stems from the MDF segment turning around off a weak, inventory-liquidation-depressed base last year, which caps it below very_good.

GREENPLY · Q2 FY-2027 · THE VERDICT

Margin power masks volume miss; new capacity delayed

Greenply delivered 11.2% operating margins (+300 bps YoY) despite 700+ bps raw material cost inflation—a genuine operational win. But the company cut MDF volume guidance (25–30% → ~20%), and both segments missed in the quarter. Capacity relief is delayed to Q4 FY28.

03 Nov 2026 · 6 min read
Reported PAT

₹42.7 Cr

+167% YoY

Core EBITDA

₹89.2 Cr

11.2% OPM, +300 bps YoY

Net debt

₹544 Cr

D/E 0.56x, well below 0.75x peak

The quarter in one line: margins beat, volumes stumbled, guidance cut

Greenply hit its operating margin targets—11.2% in Q2, +300 bps year-over-year—while absorbing 700+ basis points of raw material cost inflation. That's the real story: the company's operational leverage and premium product mix (Ecotec, TermiVax anti-termite) are genuine. But the headline is shadowed by two volume misses and a cut to full-year guidance. MDF volume growth fell to 16.1% in Q2 (half of the 25–30% FY27 target the company had guided) due to monsoon and maintenance disruptions. Plywood, fully utilized at >100%, grew only 6.1% volume YoY—well short of the 10% annual target. Management has since cut MDF FY27 growth guidance to ~20%, which H1 tracking suggests is achievable, but the gap between prior guidance and current performance is material.

Where profit actually came from

Reported PAT surged 167% to ₹42.7 Cr, but the growth is partly optical. The operating segments delivered core EBITDA of ₹89.2 Cr (11.2% OPM), holding firm despite inflationary headwinds. However, the SAMET joint venture (furniture making, 50-50 with Saloni) dragged consolidated profit: the JV posted a PAT loss of ₹12.6 Cr in Q2, of which Greenply's share was ₹6.3 Cr. This JV drag narrows consolidated NPM to just 5.3%, masking the strength of the core business. The company stopped funding the JV in Q1; the partner now handles operations and funding via advances. More importantly, Greenply is diluting its stake to 20% effective January 5, 2027, which will shift the unit to a brand-charge model and significantly reduce the drag on consolidated earnings.

Q2 FY27 Profitability, ₹ Cr
033.366.699.989.2Core EBITDA6.3JV loss (Greenply share)42.7Consolidated PAT
Operating margin is healthy; JV losses drag consolidated PAT by ₹6.3 Cr. Dilution to 20% stake will relieve this.

Management's claims vs. what holds up

Grade each guidance claim against delivered results

Maintain plywood 10% annual volume growth

Q2: 6.1% YoY (capacity-constrained at >100% utilization); H1: 9.2% YoY on track for FY if H2 delivers >11%

Overstated—execution risk

MDF 25–30% volume growth for FY27

Q2: 16.1% YoY; H1: 20.4% YoY. Management revised down to ~20% on this call.

Contradicted—guidance cut

Deliver 11–12% operating margins

Delivered 11.2% OPM in Q2, holding despite 700+ bps raw material cost inflation.

Supported—operational excellence

Debt-to-equity 0.56x, well below 0.75x peak guidance

Net debt ₹544 Cr, D/E confirmed 0.56x. On track to 0.65x by FY28 year-end per guidance.

Supported—discipline confirmed

FY27 capex ₹500 Cr on track

Plywood expansion (₹125 Cr, 15M sq m) to start Q4 FY28 at Sandila/Lucknow. MDF Vadodara/Odisha Q2 FY28. On track.

Supported—capex pacing normal

What changed on this call

1. MDF guidance downward revised. Prior call: 25–30% FY27 MDF volume growth. Q2 call: ~20% (H1 tracking 20.4% YoY, Q2 dipped to 16.1% due to monsoon and planned maintenance). The miss is execution-related, not demand-related; management remains confident on brand strength and pricing power. 2. Plywood margin expansion. Core EBITDA margin on plywood hit 10.05% in Q2 (+180 bps QoQ, +160 bps YoY), driven by Ecotec premium mix (TermiVax anti-termite and pre-lam volume) and operational efficiency despite inflation. This is a genuine operational upgrade. 3. Strategic shift: exiting SAMET JV. Greenply is diluting from 50-50 to ~20% stake effective January 5, 2027. The partner (Saloni) now funds operations; Greenply shifts to a brand-charge model. This removes a major consolidated earnings drag and clarifies the capital structure. 4. New revenue streams ramping. HDF flooring line (Odisha) commenced July 2026 and is ramping in Q2 FY27. Chipboard manufacturing (asset-light, <₹100 Cr capex) planned for next year or next-to-next year. These are new levers to drive growth beyond plywood/MDF.

Bull-bear ledger
  • OPM +300 bps YoY to 11.2%; genuine operational leverage

  • Premium mix (TermiVax, Ecotec) working; realisation ₹264/sq m plywood

  • New capex pipeline: ₹125 Cr plywood (₹320 Cr revenue potential), MDF Vadodara/Odisha

  • Net debt ₹544 Cr (D/E 0.56x) well below peak; capex self-funding

  • MDF volume guidance cut (25–30% → 20%); execution risk

  • Plywood capacity >100% utilized; Q2 volume growth only 6.1%

  • New capacity relief delayed to Q4 FY28; near-term growth capped

  • Competitive intensity rising (Elixir, Action TESA); margin pressure possible

  • JV dilution to 20% (Jan 5) removes consolidated drag, but timing in future

How the street is positioned

Price & valuation: The stock trades at ₹264.7 (as of 2026-11-02), down 35.74% from its all-time high of ₹411.95 but recovered +50.04% off the 52-week low of ₹176.42. It sits below the 20- and 50-day simple moving averages (₹300.13 and ₹294.88, respectively) but above the 200-day SMA of ₹264.03. The RSI of 34.2 suggests neutral momentum—neither deeply oversold nor overbought. The large drawdown from ATH reflects the market's repricing of growth and capex intensity; the stable positioning above the 200-day average suggests a floor is holding. Institutional flows: Foreign institutional investors (FII) stand at 4.44% (up +25 bps from 4.19% in the prior quarter), showing modest accumulation. Domestic institutional investors (DII) are at 31.43% (down −40 bps from 31.83%), stable long-term. Promoter stake unchanged at 51.93%. No insider selling signal in recent bulk/block deals; the most recent activity (April 2026) was at ₹286–288, and the current price of ₹264.7 is below that level. The absence of promoter/insider-linked selling near the highs is a subtle positive signal. Volume trend: Trading volume is increasing, which can signal base-building or accumulation. The combination of FII accumulation, DII stability, rising volume, and no insider selling suggests institutional investors are not panicking despite the guidance cut and 35% drawdown.

Risks, ranked by how much they should concern a holder

What can go wrong, and why it matters

MDF volume misses FY27 20% target

Medium

MDF is higher-margin (15–16% EBITDA); shortfall below 20% would signal brand/competitive weakness, not just seasonality. Guidance miss two quarters in a row would erode credibility.

Plywood H2 growth <11% (needed to hit 10% annual target)

Medium

Capacity is already >100% utilized. If H2 demand softens or Odisha ramp delays, full-year target slips. Signals structural capacity headwind, not temporary disruption.

Sandila expansion (₹125 Cr capex, Q4 FY28 start) delayed or underperforms

Medium

This expansion anchors long-term growth narrative and ROIC assumptions. Delays or low utilization would push ROI down and extend capacity-constrained period.

Margin compression from competitive intensity (Elixir, Action TESA, pricing wars)

Medium

MDF is entering a more competitive phase. If pricing power erodes faster than new entrants consolidate, margins could compress to 12–13%, wiping out the operational leverage story.

Chemical cost inflation sustained at 7–8% or rises further

Low

Management confident on passing through via product mix (Pre-lam premium). But if raw costs spike unexpectedly and mix reverts to plain boards, margin buffer shrinks.

SAMET JV dilution (Jan 5) hits execution bumps

Low

Jan 5 date is firm, but if dilution is contested or partner cannot take on full funding, consolidated drag persists longer.

What to watch next

Three metrics that resolve the debate
  • 1 · H2 FY27 volume delivery (Plywood >11%, MDF >18% growth)

    The company needs >11% plywood volume growth in H2 to hit the 10% annual target, and MDF must stay >18% to average 20% FY27. These are the proof points that monsoon/maintenance were temporary, not structural. Odisha plywood ramp-up and continued Ecotec traction must show up here.

  • 2 · Odisha plywood line ramp-up (Q3–Q4 FY27) and utilization

    If the new line ramps smoothly and hits >80% utilization by Q4, it signals execution capability and near-term capacity relief. Slow ramp or soft utilization would flag capex ROI and execution risk on future Sandila expansion.

  • 3 · SAMET JV dilution closure (Jan 5) and Q3 consolidated earnings

    Dilution to 20% stake should cut the JV drag in half or more. Q3 consolidated PAT (post-dilution) should widen the gap between reported PAT and core EBITDA. If it doesn't, look for hidden issues in the JV transition or partner funding.

The number to track

From here, the single most important metric is core EBITDA margin hold. If Greenply can keep OPM at 10–11% through H2 FY27 and into FY28, despite new competitive entrants and any margin pressure from cost inflation, then the margin-expansion thesis is credible. A slip below 10% would signal that the operational leverage story is cracking.

Greenply is a steady operator in a structurally growing market (organized plywood/MDF taking share from unorganized). The Q2 beat on operating margins is genuine, and the capex roadmap (new plywood, MDF, flooring) is credible. But the volume guidance miss and the admission of execution challenges (monsoon, capacity, competitive intensity) mean near-term growth is constrained. The stock's 35% drawdown from ATH is pricing in both the guidance cut and the capex cycle ahead. At current levels, this is a HOLD: not a buy for growth, and not a sell for value. Execution on H2 FY27 volumes and Odisha ramp-up will determine whether the stock reprices back toward ATH or consolidates lower. The JV dilution (Jan 5) is a near-term catalyst to watch for earnings clarification.

Informational and educational content only. Not investment advice.